Gene · 10672
Papers1,983
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,983
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Frequent ZNF217 mutations lead to transcriptional deregulation of interferon signal transduction via altered chromatin accessibility in B cell lymphoma. | Leukemia | 2023 | 37648814 | PubTator, text mining | PubMed |
| Crouch S, Painter D, Barrans SL, et al. Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network. Blood Adv. 2022;6(21):5716-5731. | Blood Adv | 2023 | 37639289 | PubTator, text mining | PubMed |
On the Value of In Vitro Cell Systems for Mechanobiology from the Perspective of Yes-Associated Protein/Transcriptional Co-Activator with a PDZ-Binding Motif and Focal Adhesion Kinase and Their Involvement in Wound Healing, Cancer, Aging, and Senescence. | Int J Mol Sci | 2023 | 37628858 | PubTator, text mining | PubMed |
| Genetic Variants Associated with the Age of Onset Identified by Whole-Exome Sequencing in Fatal Familial Insomnia. | Cells | 2023 | 37626863 | PubTator, text mining | PubMed |
| REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors. | Biosensors (Basel) | 2023 | 37622853 | PubTator, text mining | PubMed |
| Re-routing GPR56 signalling using Gα12/13 G protein chimeras. | Basic Clin Pharmacol Toxicol | 2023 | 37621135 | PubTator, text mining | PubMed |
| Machine learning models-based on integration of next-generation sequencing testing and tumor cell sizes improve subtype classification of mature B-cell neoplasms. | Front Oncol | 2023 | 37601650 | PubTator, text mining | PubMed |
| Integrin β3 directly inhibits the Gα13-p115RhoGEF interaction to regulate G protein signaling and platelet exocytosis. | Nat Commun | 2023 | 37587112 | PubTator, text mining | PubMed |
| Gα Protein Signaling Bias at Serotonin 1A Receptor. | Mol Pharmacol | 2023 | 37567783 | PubTator, text mining | PubMed |
Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop. | Virchows Arch | 2023 | 37555980 | PubTator, text mining | PubMed |
| A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma. | Blood Adv | 2023 | 37552109 | PubTator, text mining | PubMed |
| Downregulation of VRK1 Inhibits Progression of Lung Squamous Cell Carcinoma through DNA Damage. | Can Respir J | 2023 | 37547297 | PubTator, text mining | PubMed |
| Signaling specificity and kinetics of the human metabotropic glutamate receptors. | bioRxiv | 2023 | 37546908 | PubTator, text mining | PubMed |
| Case report: Clinicopathological and molecular characteristics of pediatric-type follicular lymphoma. | Front Pediatr | 2023 | 37539011 | PubTator, text mining | PubMed |
| Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology. | Virchows Arch | 2023 | 37530791 | PubTator, text mining | PubMed |
| Dual role of the adhesion G-protein coupled receptor ADRGE5/CD97 in glioblastoma invasion and proliferation. | J Biol Chem | 2023 | 37517698 | PubTator, text mining | PubMed |
| Lipid-correlated alterations in the transcriptome are enriched in several specific pathways in the postmortem prefrontal cortex of Japanese patients with schizophrenia. | Neuropsychopharmacol Rep | 2023 | 37498306 | PubTator, text mining | PubMed |
| Competition for cysteine acylation by C16:0 and C18:0 derived lipids is a global phenomenon in the proteome. | J Biol Chem | 2023 | 37495107 | PubTator, text mining | PubMed |
| The Usefulness of Thyroid Antibodies in the Diagnostic Approach to Autoimmune Thyroid Disease. | Antibodies (Basel) | 2023 | 37489370 | PubTator, text mining | PubMed |
| GPCRome-wide analysis of G-protein-coupling diversity using a computational biology approach. | Nat Commun | 2023 | 37468476 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10672/papers?page=8